Next-Generation Discovery Workflows
Transcriptomic Algorithm Shows Ability to Predict Progression-Free Survival in Cancer Patients
Premium
WIN Consortium researchers have shown that a prototype "digital display precision predictor" may identify patents who will live longer on treatments without progression.
Geisinger Health System Wins $3.6M NIH Grant to Study Genetics of Cancer Risk
The health system will partner with the NCI to look for new cancer risk variants in a large population biobank, in the hopes of improving screening and care.
BostonGene, Medical College of Wisconsin Partner on Pancreatic Cancer Biomarker Research
The partners will look for patterns in patients' exome sequencing and transcriptomics data to try to predict treatment response.
Genome Sequencing Identifies Myeloma Precursor Disease With High Progression Risk
Investigators flagged a set of myeloma-defining genomic events that marked precursor conditions that were prone to morph into multiple myeloma.
Germline Genetic Variants May Influence Tumor Immune Microenvironment, Treatment Response
A new study lends credence to the idea that pre-existing anti-cancer immunity depends heavily on patients' genetic background, according to one of the researchers.